UB
ALNY icon

UMB Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

UMB Bank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.8K Buy
285
+94
+49% +$28.4K ﹤0.01% 1107
2026
Q1 		$63.2K Buy
191
+177
+1,264% +$60.2K ﹤0.01% 1157
2025
Q4 		$5.57K Buy
14
+2
+17% +$885 ﹤0.01% 1994
2025
Q3 		$5.47K Buy
12
+4
+50% +$1.63K ﹤0.01% 1859
2025
Q2 		$2.61K Buy
8
+6
+300% +$1.66K ﹤0.01% 1968
2025
Q1 		$540 Buy
+2
New +$514 ﹤0.01% 2048
2023
Q3 		– Sell
-5
Closed -$950 – 1691
2023
Q2 		$950 Buy
+5
New +$991 ﹤0.01% 1596
2023
Q1 		– Sell
-4
Closed -$1K – 1697
2022
Q4 		$1K Buy
+4
New +$853 ﹤0.01% 1583
2022
Q3 		– Sell
-173
Closed -$25K – 1737
2022
Q2 		$25K Hold
173
– – ﹤0.01% 1087
2022
Q1 		$28K Buy
+173
New +$26.4K ﹤0.01% 1121

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's ALNY Position: Q2 2026 in Review

UMB Bank increased its Alnylam Pharmaceuticals (ALNY) stake by 49% in Q2 2026, buying an estimated $28.4K and bringing the position to 285 shares worth $85.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

UMB Bank first reported a position in ALNY in Q1 2022 and has held it in 10 quarters since. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • UMB Bank held 285 shares of Alnylam Pharmaceuticals worth $85.8K as of Q2 2026.
  • UMB Bank bought 94 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $28.4K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1107 holding.
  • UMB Bank first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.